Back to search

A phase 2 study of an allogeneic GM-CSF gene-transduced prostate cancer cell line vaccine in patients with metastatic hormone-refractory prostate cancer (HRPC)

Data up to Jan 2025

Published2004
Citations43
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

A phase 2 study of an allogeneic GM-CSF gene-transduced prostate cancer cell line vaccine… (2004) – Journal of Clinical Oncology | Metascience Observatory Explorer